Gilead Sciences : Slovakia EFPIA Report 2024 (in English) (gilead sciences slovakia efpia report 2024 in english)
GILD
Published on 06/24/2025 at 09:19
Date of Publication: 30 June 2025
Full Name
Health personnel: The place of the main practice
Healthcare organizations: place of registration
The main practice country
Address (street / number / box) of the main practice
Unique identification number OPTIONAL
Donations & grants
Contributions to costs of Events
Fee for service and consultancy
Total
Optional
Sponsorship agreements with HCOs/third parties appointed by HCOs to manage an Event
Registration Fees
Travel & Accommodation
Fees
Related expenses agreed in the fee for service or consultancy contract, including travel & accommodation relevant to the contract
HCPs
INDIVIDUAL NAMED DISCLOSURE - one line per HCP (i.e. all transfers of value during a year for an individual HCP will be summed up: itemization should be available for the individual Recipient or public authorities' consultation only, as appropriate) ◻
OTHER, NOT INCLUDED ABOVE - where information cannot be disclosed on an individual basis for legal reasons ◻
Aggregate amount attributable to transfers of value to such Recipients◻
Number of Recipients in aggregate disclosure◻
% of the number of Recipients included in the aggregate disclosure in the total number of Recipients disclosed ◻
HCOs
INDIVIDUAL NAMED DISCLOSURE - one line per HCO (i.e. all transfers of value during a year for an individual HCO will be summed up: itemization should be available for the individual Recipient or public authorities' consultation only, as appropriate) ◻
KAMEAT, s.r.o.
Nové Mesto nad Vá
Slovakia
Dibrovova 25
0.00
3200.00
0.00
0.00
0.00
0.00
3200.00
OTHER, NOT INCLUDED ABOVE - where information cannot be disclosed on an individual basis for legal reasons ◻
Aggregate amount attributable to transfers of value to such Recipients◻
Number of Recipients in aggregate disclosure◻
% of the number of Recipients included in the aggregate disclosure in the total number of Recipients disclosed ◻
0.00
0.00
0.00
0.00
0.00
0.00
0.00
&D
AGGREGATE DISCLOSURE
R
Transfers of Value Research & Development as defined
11191.00
Disclaimer
Gilead Sciences Inc. published this content on June 24, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on June 24, 2025 at 13:17 UTC.